Healthcare provider profile · identity verified

Catherine Dawgert

Nurse Practitioner · PITTSBURGH, PA · NPI 1831561588

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	335	45
Levothyroxine Sodium	Levothyroxine Sodium	276	37
Losartan Potassium	Losartan Potassium	258	41
Famotidine	Famotidine	240	29
Albuterol Sulfate Hfa	Albuterol Sulfate	232	39
Atorvastatin Calcium	Atorvastatin Calcium	229	43
Pantoprazole Sodium	Pantoprazole Sodium	210	31
Mirtazapine	Mirtazapine	182	23
Omeprazole	Omeprazole	181	24
Gabapentin	Gabapentin	151	19
Ventolin Hfa	Albuterol Sulfate	129	20
Lisinopril	Lisinopril	126	19
Fluticasone Propionate	Fluticasone Propionate	115	25
Simvastatin	Simvastatin	112	18
Diclofenac Sodium	Diclofenac Sodium	104	25
Metoprolol Tartrate	Metoprolol Tartrate	104	13
Trazodone Hcl	Trazodone Hcl	102	19
Furosemide	Furosemide	101	17
Metformin Hcl	Metformin Hcl	101	19
Montelukast Sodium	Montelukast Sodium	100	14
Duloxetine Hcl	Duloxetine Hcl	83	16
Amitriptyline Hcl	Amitriptyline Hcl	82	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	74	15
Citalopram Hbr	Citalopram Hydrobromide	71	suppressed
Celecoxib	Celecoxib	62	suppressed
Metoprolol Succinate	Metoprolol Succinate	62	suppressed
Metformin Hcl Er	Metformin Hcl	60	17
Farxiga	Dapagliflozin Propanediol	57	suppressed
Eliquis	Apixaban	54	suppressed
Jardiance	Empagliflozin	48	12
Sertraline Hcl	Sertraline Hcl	47	12
Advair Hfa	Fluticasone Propion/Salmeterol	44	suppressed
Prazosin Hcl	Prazosin Hcl	43	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	43	12
Naproxen	Naproxen	42	suppressed
Sucralfate	Sucralfate	37	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	36	suppressed
Prednisone	Prednisone	36	15
Hydrochlorothiazide	Hydrochlorothiazide	33	suppressed
Donepezil Hcl	Donepezil Hcl	29	suppressed
Glipizide Er	Glipizide	28	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	28	suppressed
Oxycodone Hcl	Oxycodone Hcl	27	suppressed
Pravastatin Sodium	Pravastatin Sodium	27	suppressed
Alendronate Sodium	Alendronate Sodium	26	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	25	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	25	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	24	18
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	24	suppressed
Breo Ellipta	Fluticasone/Vilanterol	24	suppressed
Ketoconazole	Ketoconazole	24	suppressed
Betamethasone Dipropionate	Betamethasone Dipropionate	23	suppressed
Paroxetine Hcl	Paroxetine Hcl	23	suppressed
Levetiracetam	Levetiracetam	22	suppressed
Terazosin Hcl	Terazosin Hcl	22	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	21	suppressed
Levofloxacin	Levofloxacin	21	suppressed
Carvedilol	Carvedilol	20	suppressed
Ozempic	Semaglutide	20	suppressed
Hydralazine Hcl	Hydralazine Hcl	19	suppressed
Memantine Hcl	Memantine Hcl	18	suppressed
Trulicity	Dulaglutide	18	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	17	suppressed
Warfarin Sodium	Warfarin Sodium	17	suppressed
Allopurinol	Allopurinol	16	suppressed
Finasteride	Finasteride	16	suppressed
Benazepril Hcl	Benazepril Hcl	15	suppressed
Azelastine Hcl	Azelastine Hcl	14	suppressed
Baclofen	Baclofen	14	suppressed
Hydrocortisone	Hydrocortisone	14	suppressed
Pilocarpine Hcl	Pilocarpine Hcl	14	suppressed
Potassium Chloride	Potassium Chloride	14	suppressed
Ropinirole Hcl	Ropinirole Hcl	14	suppressed
Tiadylt Er	Diltiazem Hcl	14	suppressed
Atenolol	Atenolol	13	suppressed
Azithromycin	Azithromycin	13	suppressed
Clopidogrel	Clopidogrel Bisulfate	13	suppressed
Meloxicam	Meloxicam	13	suppressed
Ondansetron Odt	Ondansetron	13	suppressed
Mounjaro	Tirzepatide	12	suppressed
Primidone	Primidone	12	suppressed
Risperidone	Risperidone	12	suppressed
Spironolactone	Spironolactone	12	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error